Skip to main content
AAN.com
Brief Communications
March 1, 1987

Akathisia in idiopahic Parkinson's disease

March 1987 issue
37 (3) 477

Abstract

Akathisia is a little-studied symptom of Parkinson's disease. Interviews of 100 patients with idiopathic Parkinson's disease indicated that 68% periodically experienced the need to move and inability to remain still, usually because of well-defined causes such as parkinsonism and sensory complaints. Twenty-six patients could not explain the inability to remain still, a state of true akathisia. This disputes the common belief that akathisia represents simply the need to move for relief of discomfort imposed by rigidity or lack of movement, and emphasizes the need to distinguish between true akathisia and other, more common causes for the need to move experienced by parkinsonian patients.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 37Number 3March 1987
Pages: 477
PubMed: 3822142

Publication History

Published online: March 1, 1987
Published in print: March 1987

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Anthony E. Lang, MD, FRCP(C)
Movement Disorders Clinic, Toronto Western Hospital, Toronto, Ontario, Canada.
Kathene Johnson, BSc
Movement Disorders Clinic, Toronto Western Hospital, Toronto, Ontario, Canada.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review, Genes, 14, 3, (616), (2023).https://doi.org/10.3390/genes14030616
    Crossref
  2. Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives, Expert Review of Neurotherapeutics, 23, 1, (25-43), (2023).https://doi.org/10.1080/14737175.2023.2173576
    Crossref
  3. Akathisia after chronic usage of synthetic cathinones: A case study, Frontiers in Psychiatry, 13, (2022).https://doi.org/10.3389/fpsyt.2022.1046486
    Crossref
  4. Acute akathisia following initiation of opicapone: A case report, Clinical Parkinsonism & Related Disorders, 7, (100154), (2022).https://doi.org/10.1016/j.prdoa.2022.100154
    Crossref
  5. Akathisia in Parkinson's Disease: A Comperative Cross-Sectional Study, Turkish Journal Of Neurology, (2021).https://doi.org/10.4274/tnd.2021.15689
    Crossref
  6. Nonmotor problems in Parkinson disease, Principles and Practice of Movement Disorders, (234-248.e7), (2021).https://doi.org/10.1016/B978-0-323-31071-0.00008-1
    Crossref
  7. Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics, Psychopharmacology of Neurologic Disease, (83-121), (2019).https://doi.org/10.1016/B978-0-444-64012-3.00007-1
    Crossref
  8. Restless legs syndrome in Parkinson's disease and increased cardiovascular risk, Arquivos de Neuro-Psiquiatria, 76, 11, (731-735), (2018).https://doi.org/10.1590/0004-282x20180114
    Crossref
  9. An overview of sleep and circadian dysfunction in Parkinson's disease, Journal of Sleep Research, 27, 3, (2018).https://doi.org/10.1111/jsr.12673
    Crossref
  10. Sleep in Neurodegenerative Diseases, Sleep Medicine Clinics, 11, 1, (1-18), (2016).https://doi.org/10.1016/j.jsmc.2015.10.011
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share